Douglas Flora: The August Issue of AI in Precision Oncology is Here!

Douglas Flora shared on LinkedIn:

“The August Issue of AI in Precision Oncology is Here!

I’m excited to share that our latest issue is now available. It focuses entirely on the applications of artificial intelligence in the future of cancer screening. This issue covers these important advances in some detail across a number of strategies and tumors.

This article is the best I’ve found on this topic. Thank you to authors Maysaa El Zoghbi and Seth Gross for bringing your great manuscript to AI in Precision Oncology.

Please consider sharing this with the gastroenterologists in your network—it’s a must-read for anyone in the field.

Check out the complete Table of Contents here.”

Comprehensive Review of the Current State-of-the-Art in AI-Driven Colorectal Cancer Screening

Authors: Maysaa El Zoghbi and Seth Gross

Source: Douglas Flora/LinkedIn

For more posts by Douglas Flora, visit oncodaily.com

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.